Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies
Condition:   Centronuclear Myopathy Intervention:   Drug: DYN101 Sponsor:   Dynacure SAS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2019 Category: Research Source Type: clinical trials

Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies
Condition:   Centronuclear Myopathy Intervention:   Other: Standardized strength, respiratory and motor function assessments Sponsors:   Institut de Myologie, France;   Dynacure Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2017 Category: Research Source Type: clinical trials